The identification of genetic vulnerabilities in head and neck cancers for the development of novel therapies

ABSTRACT: CRISPR/Cas9 lethality screens in a set of Asian head and neck cancer cell lines to identify novel targets.

PROVIDER: EGAS00001002204 | EGA |

REPOSITORIES: EGA